scholarly journals Detection of Physiological Signals Based on Graphene Using a Simple and Low-Cost Method

Sensors ◽  
2019 ◽  
Vol 19 (7) ◽  
pp. 1656 ◽  
Author(s):  
Liping Xie ◽  
Xingyu Zi ◽  
Qingshi Meng ◽  
Zhiwen Liu ◽  
Lisheng Xu

Despite that graphene has been extensively used in flexible wearable sensors, it remains an unmet need to fabricate a graphene-based sensor by a simple and low-cost method. Here, graphene nanoplatelets (GNPs) are prepared by thermal expansion method, and a sensor is fabricated by sealing of a graphene sheet with polyurethane (PU) medical film. Compared with other graphene-based sensors, it greatly simplifies the fabrication process and enables the effective measurement of signals. The resistance of graphene sheet changes linearly with the deformation of the graphene sensor, which lays a solid foundation for the detection of physiological signals. A signal processing circuit is developed to output the physiological signals in the form of electrical signals. The sensor was used to measure finger bending motion signals, respiration signals and pulse wave signals. All the results demonstrate that the graphene sensor fabricated by the simple and low-cost method is a promising platform for physiological signal measurement.

2019 ◽  
Vol 126 (3) ◽  
pp. 717-729 ◽  
Author(s):  
Kimberly A. Ingraham ◽  
Daniel P. Ferris ◽  
C. David Remy

Body-in-the-loop optimization algorithms have the capability to automatically tune the parameters of robotic prostheses and exoskeletons to minimize the metabolic energy expenditure of the user. However, current body-in-the-loop algorithms rely on indirect calorimetry to obtain measurements of energy cost, which are noisy, sparsely sampled, time-delayed, and require wearing a respiratory mask. To improve these algorithms, the goal of this work is to predict a user’s steady-state energy cost quickly and accurately using physiological signals obtained from portable, wearable sensors. In this paper, we quantified physiological signal salience to discover which signals, or groups of signals, have the best predictive capability when estimating metabolic energy cost. We collected data from 10 healthy individuals performing 6 activities (walking, incline walking, backward walking, running, cycling, and stair climbing) at various speeds or intensities. Subjects wore a suite of physiological sensors that measured breath frequency and volume, limb accelerations, lower limb EMG, heart rate, electrodermal activity, skin temperature, and oxygen saturation; indirect calorimetry was used to establish the ‘ground truth’ energy cost for each activity. Evaluating Pearson’s correlation coefficients and single and multiple linear regression models with cross validation (leave-one- subject-out and leave-one- task-out), we found that 1) filtering the accelerations and EMG signals improved their predictive power, 2) global signals (e.g., heart rate, electrodermal activity) were more sensitive to unknown subjects than tasks, while local signals (e.g., accelerations) were more sensitive to unknown tasks than subjects, and 3) good predictive performance was obtained combining a small number of signals (4–5) from multiple sensor modalities. NEW & NOTEWORTHY In this paper, we systematically compare a large set of physiological signals collected from portable sensors and determine which sensor signals contain the most salient information for predicting steady-state metabolic energy cost, robust to unknown subjects or tasks. This information, together with the comprehensive data set that is published in conjunction with this paper, will enable researchers and clinicians across many fields to develop novel algorithms to predict energy cost from wearable sensors.


Sensors ◽  
2020 ◽  
Vol 20 (16) ◽  
pp. 4551
Author(s):  
Muhammad Najam Dar ◽  
Muhammad Usman Akram ◽  
Sajid Gul Khawaja ◽  
Amit N. Pujari

Novel trends in affective computing are based on reliable sources of physiological signals such as Electroencephalogram (EEG), Electrocardiogram (ECG), and Galvanic Skin Response (GSR). The use of these signals provides challenges of performance improvement within a broader set of emotion classes in a less constrained real-world environment. To overcome these challenges, we propose a computational framework of 2D Convolutional Neural Network (CNN) architecture for the arrangement of 14 channels of EEG, and a combination of Long Short-Term Memory (LSTM) and 1D-CNN architecture for ECG and GSR. Our approach is subject-independent and incorporates two publicly available datasets of DREAMER and AMIGOS with low-cost, wearable sensors to extract physiological signals suitable for real-world environments. The results outperform state-of-the-art approaches for classification into four classes, namely High Valence—High Arousal, High Valence—Low Arousal, Low Valence—High Arousal, and Low Valence—Low Arousal. Emotion elicitation average accuracy of 98.73% is achieved with ECG right-channel modality, 76.65% with EEG modality, and 63.67% with GSR modality for AMIGOS. The overall highest accuracy of 99.0% for the AMIGOS dataset and 90.8% for the DREAMER dataset is achieved with multi-modal fusion. A strong correlation between spectral- and hidden-layer feature analysis with classification performance suggests the efficacy of the proposed method for significant feature extraction and higher emotion elicitation performance to a broader context for less constrained environments.


2021 ◽  
pp. 1-7
Author(s):  
Diane Stephenson ◽  
Reham Badawy ◽  
Soania Mathur ◽  
Maria Tome ◽  
Lynn Rochester

The burden of Parkinson’s disease (PD) continues to grow at an unsustainable pace particularly given that it now represents the fastest growing brain disease. Despite seminal discoveries in genetics and pathogenesis, people living with PD oftentimes wait years to obtain an accurate diagnosis and have no way to know their own prognostic fate once they do learn they have the disease. Currently, there is no objective biomarker to measure the onset, progression, and severity of PD along the disease continuum. Without such tools, the effectiveness of any given treatment, experimental or conventional cannot be measured. Such tools are urgently needed now more than ever given the rich number of new candidate therapies in the pipeline. Over the last decade, millions of dollars have been directed to identify biomarkers to inform progression of PD typically using molecular, fluid or imaging modalities). These efforts have produced novel insights in our understanding of PD including mechanistic targets, disease subtypes and imaging biomarkers. While we have learned a lot along the way, implementation of robust disease progression biomarkers as tools for quantifying changes in disease status or severity remains elusive. Biomarkers have improved health outcomes and led to accelerated drug approvals in key areas of unmet need such as oncology. Quantitative biomarker measures such as HbA1c a standard test for the monitoring of diabetes has impacted patient care and management, both for the healthcare professionals and the patient community. Such advances accelerate opportunities for early intervention including prevention of disease in high-risk individuals. In PD, progression markers are needed at all stages of the disease in order to catalyze drug development—this allows interventions aimed to halt or slow disease progression, very early, but also facilitates symptomatic treatments at moderate stages of the disease. Recently, attention has turned to the role of digital health technologies to complement the traditional modalities as they are relatively low cost, objective and scalable. Success in this endeavor would be transformative for clinical research and therapeutic development. Consequently, significant investment has led to a number of collaborative efforts to identify and validate suitable digital biomarkers of disease progression.


Micromachines ◽  
2021 ◽  
Vol 12 (3) ◽  
pp. 337
Author(s):  
Navneet Soin ◽  
Sam J. Fishlock ◽  
Colin Kelsey ◽  
Suzanne Smith

The use of rapid point-of-care (PoC) diagnostics in conjunction with physiological signal monitoring has seen tremendous progress in their availability and uptake, particularly in low- and middle-income countries (LMICs). However, to truly overcome infrastructural and resource constraints, there is an urgent need for self-powered devices which can enable on-demand and/or continuous monitoring of patients. The past decade has seen the rapid rise of triboelectric nanogenerators (TENGs) as the choice for high-efficiency energy harvesting for developing self-powered systems as well as for use as sensors. This review provides an overview of the current state of the art of such wearable sensors and end-to-end solutions for physiological and biomarker monitoring. We further discuss the current constraints and bottlenecks of these devices and systems and provide an outlook on the development of TENG-enabled PoC/monitoring devices that could eventually meet criteria formulated specifically for use in LMICs.


2021 ◽  
Vol 98 ◽  
pp. 102981
Author(s):  
Naser Hossein Motlagh ◽  
Martha A. Zaidan ◽  
Pak L. Fung ◽  
Eemil Lagerspetz ◽  
Kasimir Aula ◽  
...  

2013 ◽  
Vol 344 ◽  
pp. 107-110
Author(s):  
Shun Ren Hu ◽  
Ya Chen Gan ◽  
Ming Bao ◽  
Jing Wei Wang

For the physiological signal monitoring applications, as a micro-controller based on field programmable gate array (FPGA) physiological parameters intelligent acquisition system is given, which has the advantages of low cost, high speed, low power consumption. FPGA is responsible for the completion of pulse sensor, the temperature sensor, acceleration sensor data acquisition and serial output and so on. Focuses on the design ideas and architecture of the various subsystems of the whole system, gives the internal FPGA circuit diagram of the entire system. The whole system is easy to implement and has a very good promotional value.


2014 ◽  
Vol 2014 ◽  
pp. 1-11 ◽  
Author(s):  
Y. F. Liu ◽  
G. H. Yuan ◽  
Z. H. Jiang ◽  
Z. P. Yao

Mn3O4nanoparticle/graphene sheet (GM) composites were synthesized via a one-pot and low-cost solvothermal process in an ethanol solution. The as-prepared materials were characterized by X-ray diffraction, field emission scanning electron microscopy, and transmission electron microscopy. Results showed that the nanosized Mn3O4particles had tetragonal hausmannite structure and were successfully loaded on the graphene sheets. Moreover, the electrochemical performances of GM composites produced by different mass percents of Mn2+/graphite oxide (GO) were evaluated by means of cyclic voltammetry and galvanostatic charge-discharge studies. The composite prepared with Mn2+/GO mass percent of 10 : 90 showed a high specific capacitance of 245 F/g at 5 mV/s in the 6 M KOH solution and better long-term stability along with 81% of its initial capacitance after 1200 cycles at 0.5 A/g.


2017 ◽  
Vol 1 (10) ◽  
pp. 2091-2100 ◽  
Author(s):  
Daniel Manaye Kabtamu ◽  
Yu-Chung Chang ◽  
Guan-Yi Lin ◽  
Anteneh Wodaje Bayeh ◽  
Jian-Yu Chen ◽  
...  

This paper presents a three-dimensional annealed tungsten trioxide nanowire/graphene sheet (3D annealed WO3 NWs/GS) foam as an excellent and low-cost electrocatalyst.


Sign in / Sign up

Export Citation Format

Share Document